Transcode Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $753 |
Gross Profit | -142 | -141 | ||
EBITDA | -2,183 | -5,043 | -3,175 | |
EBIT | -2,310 | -5,186 | -3,317 | |
Net Income | -5,915 | -2,321 | -5,190 | -3,326 |
Net Change In Cash | 0 | 0 | 0 | 753 |
Free Cash Flow | -3,146 | -3,925 | -2,344 | -3,941 |
Cash | 5,811 | 1,875 | 3,354 | 4,913 |
Basic Shares | 696 | 14,685 | 7,051 | 5,142 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -516 | -98 | -42 | |
EBITDA | -17,973 | -17,466 | -6,108 | |
EBIT | -18,490 | -17,564 | -6,151 | |
Net Income | -16,785,572 | -18,546 | -35,129 | -6,938 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -13,335,947 | -18,110 | -15,863 | -5,521 |
Cash | 5,811,064 | 2,767 | 4,968 | 20,825 |
Basic Shares | 356,115 | 179 | 16 | 16 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$45.93 |
2024-09-30 | -$5.28 |
2024-06-30 | -$976.80 |
2024-03-31 | -$22.84 |
